The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of pembrolizumab and lenvatinib in platinum sensitive recurrent ovarian cancer.
 
Smadar Bauer
Honoraria - MSD/Merck
 
Akram Saad
No Relationships to Disclose
 
Inbal Greenhouse
No Relationships to Disclose
 
Anna Ruth Rapoport
No Relationships to Disclose
 
Shir Shahar
No Relationships to Disclose
 
Tania Barnatan
No Relationships to Disclose
 
Ronit Satchi-Fainaro
Leadership - Teva
Stock and Other Ownership Interests - Teva
Research Funding - Merck KGaA (Inst)
 
Ronnie Shapira-Frommer
Honoraria - AstraZeneca; AstraZeneca; Bristol-Myers Squibb; medison; MSD; MSD (Inst); MSD Oncology; Neopharm; Novartis; Roche
Consulting or Advisory Role - MSD Oncology; Novartis